Larissa Lezina

Leicester, ENG LE17RH, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

CD320 Receptor and Vitamin B12 as Potential Targets for Anti-Cancer Therapy.

CD320 Receptor and Vitamin B12 as Potential Targets for Anti-Cancer Therapy.

Journal: International journal of molecular sciences
Published: April 29, 2025

Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes.

Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes.

Journal: Nano letters
Published: October 30, 2023

An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy.

An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy.

Journal: Scientific reports
Published: May 15, 2023

p53-Independent Effects of Set7/9 Lysine Methyltransferase on Metabolism of Non-Small Cell Lung Cancer Cells.

p53-Independent Effects of Set7/9 Lysine Methyltransferase on Metabolism of Non-Small Cell Lung Cancer Cells.

Journal: Frontiers in oncology
Published: May 07, 2021

GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice.

GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice.

Journal: The Journal of biological chemistry
Published: January 12, 2021

Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis.

Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis.

Journal: Cell cycle (Georgetown, Tex.)
Published: August 16, 2018

Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor.

Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor.

Journal: Nano letters
Published: July 04, 2018

CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM.

CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM.

Journal: Blood advances
Published: December 26, 2017

Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.

Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.

Journal: The Journal of biological chemistry
Published: May 06, 2016

Human EHMT2/G9a activates p53 through methylation-independent mechanism.

Human EHMT2/G9a activates p53 through methylation-independent mechanism.

Journal: Oncogene
Published: February 03, 2016

Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells.

Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells.

Journal: Blood
Published: November 16, 2015

Characterization of novel markers of senescence and their prognostic potential in cancer.

Characterization of novel markers of senescence and their prognostic potential in cancer.

Journal: Cell death & disease
Published: July 28, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026